Nanosystems Applied to HIV Infection: Prevention and Treatments
Open Access
- 17 November 2020
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (22) , 8647
Abstract
Sexually-transmitted infections (STIs) are a global health concern worldwide as they cause acute diseases, infertility, and significant mortality. Among the bacterial, viral, and parasitic pathogens that can be sexually transmitted, human immunodeficiency virus (HIV) has caused one of the most important pandemic diseases, which is acquired immune deficiency syndrome (AIDS). 32.7 million people have died from AIDS-related illnesses since the start of the epidemic. Moreover, in 2019, 38 million people were living with HIV worldwide. The need to deal with this viral infection becomes more obvious, because it represents not only a problem for public health, but also a substantial economic problem. In this context, it is necessary to focus efforts on developing methods for prevention, detection and treatment of HIV infections that significantly reduce the number of newly infected people and provide a better quality of life for patients. For several decades, biomedical research has been developed allowing quick solutions through the contribution of effective tools. One of them is the use of polymers as vehicles, drug carrier agents, or as macromolecular prodrugs. Moreover, nanosystems (NSs) play an especially important role in the diagnosis, prevention, and therapy against HIV infection. The purpose of this work is to review recent research into diverse NSs as potential candidates for prevention and treatment of HIV infection. Firstly, this review highlights the advantages of using nanosized structures for these medical applications. Furthermore, we provide an overview of different types of NSs used for preventing or combating HIV infection. Then, we briefly evaluate the most recent developments associated with prevention and treatment alternatives. Additionally, the implications of using different NSs are also addressed.Keywords
Funding Information
- Fondo para la Investigación Científica y Tecnológica (PICT-2015-2477)
- SECYT-UNC “Proyecto Consolidar” (Res. Nº 411/2018)
- retic (PT17/0015/0042)
This publication has 164 references indexed in Scilit:
- Antiretroviral Solid Drug Nanoparticles with Enhanced Oral Bioavailability: Production, Characterization, and In Vitro–In Vivo CorrelationAdvanced Healthcare Materials, 2013
- A review of nanotechnological approaches for the prophylaxis of HIV/AIDSBiomaterials, 2013
- Exploring Polymeric Micelles for Improved Delivery of Anticancer Agents: Recent Developments in Preclinical StudiesPharmaceutics, 2013
- Synergistic encapsulation of the anti-HIV agent efavirenz within mixed poloxamine/poloxamer polymeric micellesNanomedicine: Nanotechnology, Biology and Medicine, 2011
- Polyunsaturated liposomes are antiviral against hepatitis B and C viruses and HIV by decreasing cholesterol levels in infected cellsProceedings of the National Academy of Sciences, 2010
- Emerging Nanotechnology Approaches for HIV/AIDS Treatment and PreventionNanomedicine, 2010
- Mode of antiviral action of silver nanoparticles against HIV-1Journal of Nanobiotechnology, 2010
- The transport of anti-HIV drugs across blood–CNS interfaces: Summary of current knowledge and recommendations for further researchAntiviral Research, 2009
- A Novel Anti-HIV Dextrin–Zidovudine Conjugate Improving the Pharmacokinetics of Zidovudine in RatsAAPS PharmSciTech, 2008
- Inhibition of HIV Fusion with Multivalent Gold NanoparticlesJournal of the American Chemical Society, 2008